Devrim Cabuk
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Cancer Risks and Factors
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 3
- Cancer survivorship and care 1
- Cancer Risks and Factors 1
- Lung Cancer Research Studies 1
- HER2/EGFR in Cancer Research 1
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Gül Başaran (3 shared papers)Faysal Dane (3 shared papers)Perran Fulden Yumuk (3 shared papers)Nazım Serdar Turhal (2 shared papers)Meltem Ekenel (1 shared paper)Çiğdem Çelikel (1 shared paper)Mahmut Bahadir Gulluoglu (1 shared paper)Taner Korkmaz (1 shared paper)
- Journals
- Medical Oncology (2 papers)Oncology (1 paper)Anti-Cancer Drugs (1 paper)JAMA (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- Türkiye
In The Last Decade
Devrim Cabuk
6 papers receiving 405 citations
Devrim Cabuk's Hit Papers
Peers
Comparison fields: 5 of 31
- Oncology 320
- Cancer Research 26
- Pulmonary and Respiratory Medicine 51
- Economics and Econometrics 24
- Molecular Biology 21
Countries citing papers authored by Devrim Cabuk
This map shows the geographic impact of Devrim Cabuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devrim Cabuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devrim Cabuk more than expected).
Fields of papers citing papers by Devrim Cabuk
This network shows the impact of papers produced by Devrim Cabuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devrim Cabuk. The network helps show where Devrim Cabuk may publish in the future.
Co-authors
The 12 scholars most cited alongside Devrim Cabuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer Hit paper breakdown → | 2022 | 345 |
| 2 | 2007 | 34 | |
| 3 | 2010 | 21 | |
| 4 | 2010 | 18 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 1 |
About Devrim Cabuk
Devrim Cabuk is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Nuclear Energy and Engineering, having authored 6 papers that have together received 420 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Advanced Breast Cancer Therapies (1 paper), Cancer survivorship and care (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Cancer Risks and Factors (1 paper), Lung Cancer Research Studies (1 paper), HER2/EGFR in Cancer Research (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Oncology (320 citations), Cancer Research (26 citations), Pulmonary and Respiratory Medicine (51 citations), Economics and Econometrics (24 citations) and Molecular Biology (21 citations). Devrim Cabuk has collaborated with scholars based in Türkiye. Frequent co-authors include Gül Başaran, Faysal Dane, Perran Fulden Yumuk, Nazım Serdar Turhal, Meltem Ekenel, Çiğdem Çelikel, Mahmut Bahadir Gulluoglu, Taner Korkmaz, Hale Başak Çağlar and S. Seber. Their work appears in journals such as Medical Oncology, Oncology, Anti-Cancer Drugs, JAMA and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.